A new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair

一种治疗和预防血管内动脉瘤修复术后内漏的新治疗剂

• 批准号: 205369
• 负责人: Lerouge Sophie
• 金额: $ 11.29万
• 依托单位: Centre hospitalier de l'Universit de Montral (CHUM)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-03-01 至 2011-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=205369&lang=en
• 关键词: Abdominal Aortic Aneurysm; Animal Model; Embolisation; Endoleaks; Endovascular Treatment; Sclerosis

Aortic aneurysms (AA) are dilatations of a large vessel in the abdomen, present in approximately 5% of the population. They are usually caused by atherosclerosis. This dilatation can lead to aneurysm rupture which is a life-threatening event. The classica

主动脉瘤（AA）是腹部大血管的扩张，大约有5％的人口。它们通常是由动脉粥样硬化引起的。这种扩张会导致动脉瘤破裂，这是一个威胁生命的事件。 Classica